Search Results - "ABRAMS, S. I"

Refine Results
  1. 1

    How tumours escape mass destruction by Stewart, T J, Abrams, S I

    Published in Oncogene (06-10-2008)
    “…It is now well established that the immune system can control neoplastic development and growth in a process termed immunosurveillance. A link between host…”
    Get full text
    Journal Article
  2. 2

    Regression of Extensive Pulmonary Metastases in Mice by Adoptive Transfer of Antigen-Specific CD8+ CTL Reactive Against Tumor Cells Expressing a Naturally Occurring Rejection Epitope by Ryan, Mary Hilburger, Bristol, J. Andrew, McDuffie, Elwood, Abrams, Scott I

    Published in The Journal of immunology (1950) (15-10-2001)
    “…In this study, we developed a mouse model of adoptive immunotherapy reflecting immune recognition of syngeneic tumor cells naturally expressing an endogenous…”
    Get full text
    Journal Article
  3. 3

    A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumors by Khleif, S N, Abrams, S I, Hamilton, J M, Bergmann-Leitner, E, Chen, A, Bastian, A, Bernstein, S, Chung, Y, Allegra, C J, Schlom, J

    Published in Journal of immunotherapy (1997) (01-03-1999)
    “…Mutations in the ras genes occur in 20% of all human cancers. These genes, in turn, produce mutated proteins that are unique to cancer cells, rendering them…”
    Get more information
    Journal Article
  4. 4

    Characterization of CD8+ cytotoxic T lymphocyte/tumor cell interactions reflecting recognition of an endogenously expressed murine wild-type p53 determinant by RYAN, Mary Hilburger, ABRAMS, Scott I

    Published in Cancer Immunology, Immunotherapy (01-01-2001)
    “…p53 mutations are frequently found in human cancers and are often associated with the overexpression of wild-type (WT) protein or peptide sequences, supporting…”
    Get full text
    Journal Article
  5. 5

    Mutant ras epitopes as targets for cancer vaccines by Abrams, S I, Hand, P H, Tsang, K Y, Schlom, J

    Published in Seminars in oncology (01-02-1996)
    “…The ras p21 proto-oncogenes (ie, K-ras, H-ras, N-ras) encode a family of proteins vital to cellular signaling and function. Point mutations in these genes have…”
    Get more information
    Journal Article
  6. 6

    Influence of interferon γ on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attack by BERGMANN-LEITNER, E. S, ABRAMS, S. I

    Published in Cancer Immunology, Immunotherapy (01-07-2000)
    “…The inability of certain neoplastic populations to undergo Fas-mediated death by immune effector mechanisms may confer a selective survival advantage, which…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Strategies in the development of recombinant vaccines for colon cancer by Schlom, J, Tsang, K Y, Kantor, J A, Abrams, S I, Zaremba, S, Greiner, J, Hodge, J W

    Published in Seminars in oncology (01-12-1999)
    “…A new era involving the evaluation of recombinant vaccines for colon cancer has begun with the concurrent emergence of insights and technologies in the fields…”
    Get more information
    Journal Article
  9. 9

    Sensitivity of T cells to anti-CD3-stimulated suicide is independent of functional phenotype by Russell, J H, Rush, B J, Abrams, S I, Wang, R

    Published in European journal of immunology (01-06-1992)
    “…We have examined mixed populations and cloned murine CD4+ T cell lines for their sensitivity to anti-CD3-stimulated suicide. The sensitivity of CD4+ clones to…”
    Get more information
    Journal Article
  10. 10

    Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytes by BERGMANN-LEITNER, Elke S, ABRAMS, Scott I

    Published in Cancer Immunology, Immunotherapy (01-11-2001)
    “…Certain anti-neoplastic agents at subtoxic doses may exert immunomodulatory effects, which alter the expression of specific tumor cell surface molecules. We…”
    Get full text
    Journal Article
  11. 11

    Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism by Brahmi, Z, Bray, RA, Abrams, SI

    Published in The Journal of immunology (1950) (01-12-1985)
    “…In this study, we examined the functional status of human natural killer (NK) cells after their direct interaction with the NK-sensitive tumor target cell…”
    Get full text
    Journal Article
  12. 12

    CD4+ T lymphocyte-induced target cell detachment. A model for T cell- mediated lytic and nonlytic inflammatory processes by Abrams, SI, Russell, JH

    Published in The Journal of immunology (1950) (15-01-1991)
    “…We have been exploring the hypothesis that T lymphocytes have the potential to mediate immune damage through nonlytic disruption of tissue organization. In…”
    Get full text
    Journal Article
  13. 13

    Compared mechanisms of tumor cytolysis by human natural killer cells and activated polymorphonuclear leukocytes by Abrams, SI, Brahmi, Z

    Published in The Journal of immunology (1950) (01-06-1984)
    “…The mechanism(s) of natural killer (NK) cell-mediated cytotoxicity (CMC) remains largely unknown. In this study, we investigated the possibility of human NK…”
    Get full text
    Journal Article
  14. 14

    Differential Role of Fas/Fas Ligand Interactions in Cytolysis of Primary and Metastatic Colon Carcinoma Cell Lines by Human Antigen-Specific CD8+ CTL by Bergmann-Leitner, Elke S, Abrams, Scott I

    Published in The Journal of immunology (1950) (01-05-2000)
    “…We have previously identified mutated ras peptides reflecting the glycine to valine substitution at position 12 as HLA-A2-restricted, CD8+ CTL neo-epitopes…”
    Get full text
    Journal Article
  15. 15

    The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism by Abrams, S I, Brahmi, Z

    Published in Cellular immunology (01-09-1986)
    “…In a recent study, we evaluated the functional status of human natural killer (NK) cells after their interaction with the NK-sensitive tumor target cell (TC),…”
    Get more information
    Journal Article
  16. 16

    Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities by Abrams, SI, Brahmi, Z

    Published in The Journal of immunology (1950) (15-03-1988)
    “…We investigated the inactivation of human NK cells, a population of large granular lymphocytes (LGL), with K562, an NK-sensitive target cell (TC) and KLCL, an…”
    Get full text
    Journal Article
  17. 17

    Mechanism of action of phorbol myristate acetate on human natural killer cell activity by Abrams, S I, Bray, R A, Brahmi, Z

    Published in Cellular immunology (01-01-1983)
    “…We have investigated the kinetics of inhibition and regeneration of human natural killer (NK) cell-mediated lysis of K562, a human erythroleukemia cell line,…”
    Get more information
    Journal Article
  18. 18

    Rational antigen modification as a strategy to upregulate or downregulate antigen recognition by Abrams, S I, Schlom, J

    Published in Current opinion in immunology (01-02-2000)
    “…Recent and rapid advances in our understanding of the cellular and molecular mechanisms of antigen recognition by CD8(+) and CD4(+) T lymphocytes have led to…”
    Get full text
    Journal Article
  19. 19

    Cytotoxic T lymphocyte-induced loss of target cell adhesion and lysis involve common and separate signaling pathways by Abrams, SI, McCulley, DE, Meleedy-Rey, P, Russell, JH

    Published in The Journal of immunology (1950) (15-03-1989)
    “…Recently, we demonstrated that an early event in the CTL-target cell (TC) interaction is loss of TC adherence to substrate. This loss of adhesion is…”
    Get full text
    Journal Article
  20. 20

    Development of a Murine Mutant Ras CD8+ CTL Peptide Epitope Variant That Possesses Enhanced MHC Class I Binding and Immunogenic Properties by Bristol, J. Andrew, Schlom, Jeffrey, Abrams, Scott I

    Published in The Journal of immunology (1950) (01-03-1998)
    “…We recently identified a murine mutant Ras p21 CD8+ CTL epitope reflecting residues 4 to 12, containing the mutation of Gly to Val at codon 12, that bound…”
    Get full text
    Journal Article